Tech Company Financing Transactions

Corridor Pharmaceuticals Funding Round

MedImmune Ventures, Quaker Partners and Osage Partners invested in a $10.8 million Series A funding round for Corridor Pharmaceuticals. The round was announced on 10/2/2009.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1122 Kenilworth Dr. 401
Towson, MD 21204
USA

Phone

410-616-0804

Website

www.corridorpharma.com

Email Address

[email protected]

Overview

Corridor Pharmaceuticals is a platform-based pulmonary and critical care company developing novel therapeutics forelevated arginase levels.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Mark Strobeck

        

Chief Scientific Officer

Peter Suzdak

        

VP - Finance

Anne Shiflett

        

Browse more venture capital transactions:

Prev: 10/2/2009: XIOtech venture capital transaction
Next: 10/3/2009: ThreatMETRIX venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary